(Q45862238)

17 December 2017

title

Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay (English)

1 reference

17 December 2017

0 references

1 reference

Pier Mannuccio Mannucci

7

object named as

Pier Mannuccio Mannucci

1 reference

17 December 2017

6

Andrea Artoni

1 reference

17 December 2017

author name string

Armando Tripodi

1

1 reference

17 December 2017

Adriana Branchi

2

1 reference

17 December 2017

Veena Chantarangkul

3

1 reference

17 December 2017

Marigrazia Clerici

4

1 reference

17 December 2017

Giuliana Merati

5

1 reference

17 December 2017

publication date

1 February 2011

1 reference

17 December 2017

Journal of Thrombosis and Thrombolysis

published in

1 reference

17 December 2017

volume

31

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

165-172

1 reference

17 December 2017

An update on the etiology and epidemiology of diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Approaches to prevention of cardiovascular complications and events in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

The risk of venous thromboembolism is markedly elevated in patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Diabetes mellitus and risk of venous thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Fibrinogen and diabetes mellitus: is it time for intervention trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Calibrated automated thrombin generation measurement in clotting plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Links between arterial and venous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Cardiovascular risk factors and venous thromboembolism: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Progress in the understanding of the protein C anticoagulant pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Microparticles and thrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Dynamic role of microparticles in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

A new era for anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

The Role of Hyperglycaemia-induced Alterations of Antithrombin III and Factor X Activation in the Thrombin Hyperactivity of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-010-0506-0

High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study

21 January 2018

1 reference

12 December 2020

Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence

1 reference

12 December 2020

Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes

1 reference

12 December 2020

Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets

1 reference

12 December 2020

Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with Type 2 diabetes

1 reference

12 December 2020

Measuring circulating cell-derived microparticles

1 reference

12 December 2020

Cell-derived microparticles in haemostasis and vascular medicine.

1 reference

12 December 2020

Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability

1 reference

12 December 2020

Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma

1 reference

12 December 2020

Protein C deficiency in insulin-dependent diabetes: a hyperglycemia-related phenomenon

1 reference

12 December 2020

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation

1 reference

12 December 2020

Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study

1 reference

12 December 2020

10.1007/S11239-010-0506-0

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1019666281

0 references

1 reference

17 December 2017